Brokerages Set Teleflex Incorporated (NYSE:TFX) Price Target at $164.63

Teleflex Incorporated (NYSE:TFX - Get Free Report) has been given a consensus recommendation of "Hold" by the eleven brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $164.63.

TFX has been the subject of a number of recent analyst reports. Royal Bank of Canada lowered their price target on Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a research note on Friday, May 2nd. Mizuho set a $155.00 price target on shares of Teleflex in a research note on Wednesday, April 16th. Bank of America cut shares of Teleflex from a "neutral" rating to an "underperform" rating and decreased their price target for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Finally, Piper Sandler reaffirmed a "neutral" rating and set a $140.00 price target (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. CANADA LIFE ASSURANCE Co boosted its holdings in Teleflex by 0.4% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock worth $3,614,000 after buying an additional 74 shares during the period. Hengehold Capital Management LLC lifted its stake in Teleflex by 7.3% in the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock worth $229,000 after purchasing an additional 88 shares in the last quarter. Exchange Traded Concepts LLC lifted its stake in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after purchasing an additional 94 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after purchasing an additional 100 shares in the last quarter. Finally, True Wealth Design LLC lifted its stake in Teleflex by 62.3% in the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock worth $48,000 after purchasing an additional 104 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Performance

TFX traded up $1.15 during trading on Friday, reaching $122.24. 392,468 shares of the company's stock were exchanged, compared to its average volume of 630,380. Teleflex has a fifty-two week low of $119.08 and a fifty-two week high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The business has a 50 day moving average price of $129.94 and a 200 day moving average price of $157.99. The company has a market capitalization of $5.40 billion, a P/E ratio of 24.30, a PEG ratio of 1.73 and a beta of 1.17.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. During the same period in the previous year, the business posted $3.21 earnings per share. The firm's revenue for the quarter was down 5.0% compared to the same quarter last year. As a group, analysts predict that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's dividend payout ratio is currently 42.90%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.